{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:11:01Z","timestamp":1793085061267,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016299","name":"Al-Ahliyya Amman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jmgm.2026.109377","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:18:51Z","timestamp":1774599531000},"page":"109377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure-based pharmacophore modeling and 3D-QSAR analysis toward the discovery of novel PAK1 inhibitors for the treatment of colorectal cancer"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4408-0560","authenticated-orcid":false,"given":"Mansour","family":"Al-Sayed Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal O.","family":"Al-Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Al-Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jmgm.2026.109377_bib1","doi-asserted-by":"crossref","first-page":"FSO","DOI":"10.2144\/fsoa-2023-0131","article-title":"Oleuropein impact on colorectal cancer","volume":"10","author":"Nsairat","year":"2024","journal-title":"Future Science OA"},{"issue":"5","key":"10.1016\/j.jmgm.2026.109377_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70123","article-title":"TRPC1 and TRPC5 in colorectal cancer: mechanisms, prognostic markers, and therapeutic targets","volume":"86","author":"Abbas","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jmgm.2026.109377_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","article-title":"Structure, biochemistry, and biology of PAK kinases","volume":"605","author":"Kumar","year":"2017","journal-title":"Gene"},{"issue":"21","key":"10.1016\/j.jmgm.2026.109377_bib4","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.7150\/thno.46913","article-title":"P21-Activated kinase 1: emerging biological functions and potential therapeutic targets in cancer","volume":"10","author":"Yao","year":"2020","journal-title":"Theranostics"},{"issue":"23","key":"10.1016\/j.jmgm.2026.109377_bib5","doi-asserted-by":"crossref","first-page":"15627","DOI":"10.1021\/acs.jmedchem.2c00756","article-title":"Development and utility of a PAK1-selective degrader","volume":"65","author":"Chow","year":"2022","journal-title":"J. Med. Chem."},{"issue":"6220","key":"10.1016\/j.jmgm.2026.109377_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jmgm.2026.109377_bib7","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-018-05935-6","article-title":"Group I paks are essential for epithelial-mesenchymal transition in an Apc-driven model of colorectal cancer","volume":"9","author":"Chow","year":"2018","journal-title":"Nat. Commun."},{"issue":"7605","key":"10.1016\/j.jmgm.2026.109377_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jmgm.2026.109377_bib9","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-18-3258","article-title":"Mutational diversity and therapy response in breast cancer: a sequencing analysis in the neoadjuvant GeparSepto trial","volume":"25","author":"Loibl","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109377_bib10","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M112.424770","article-title":"P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor \u03b2 expression and enhanced matrix metalloproteinase 9 secretion","volume":"288","author":"Goc","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2026.109377_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154820","article-title":"Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer","volume":"251","author":"Pyo","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"41","key":"10.1016\/j.jmgm.2026.109377_bib12","doi-asserted-by":"crossref","first-page":"23934","DOI":"10.1074\/jbc.270.41.23934","article-title":"Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1 (\u2217)","volume":"270","author":"Zhang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109377_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0960-9822(97)70091-5","article-title":"Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells","volume":"7","author":"Sells","year":"1997","journal-title":"Curr. Biol."},{"issue":"43","key":"10.1016\/j.jmgm.2026.109377_bib14","doi-asserted-by":"crossref","first-page":"28238","DOI":"10.1074\/jbc.273.43.28238","article-title":"Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase","volume":"273","author":"Adam","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109377_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.97.1.185","article-title":"Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway","volume":"97","author":"Mira","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109377_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/annonc\/mdw184","article-title":"P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer","volume":"27","author":"Jagadeeshan","year":"2016","journal-title":"Ann. Oncol."},{"issue":"19","key":"10.1016\/j.jmgm.2026.109377_bib17","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/s41388-018-0667-4","article-title":"Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis","volume":"38","author":"Williams","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109377_bib18","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms20112783","article-title":"A structure-based drug discovery paradigm","volume":"20","author":"Batool","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109377_bib19","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jmgm.2026.109377_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1468","article-title":"Next generation 3D pharmacophore modeling","volume":"10","author":"Schaller","year":"2020","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jmgm.2026.109377_bib21","first-page":"582","article-title":"Applications of QSAR study in drug design","volume":"6","author":"Abdel-Ilah","year":"2017","journal-title":"Int. J. Eng. Res. Technol."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109377_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.13160\/ricns.2016.9.3.161","article-title":"Molecular docking studies of p21-Activated Kinase-1 (PAK1) inhibitors","volume":"9","author":"Balupuri","year":"2016","journal-title":"J. Chosun Nat. Sci."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109377_bib23","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1080\/07391102.2019.1659855","article-title":"A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1)","volume":"38","author":"Shahinozzaman","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109377_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103168","article-title":"Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the evaluation of their anti-cancer activity","volume":"91","author":"Song","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109377_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1039\/D2MD00285J","article-title":"QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y(12)) antagonist","volume":"14","author":"Al-Najjar","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109377_bib26","unstructured":"Lu, H., M. Lei, and U. Schulze-Gahmen, Crystal Structure of the Complex Between Human Pak1-kinase and 3-hydroxystaurosporine."},{"issue":"40","key":"10.1016\/j.jmgm.2026.109377_bib27","doi-asserted-by":"crossref","first-page":"29105","DOI":"10.1074\/jbc.M113.510933","article-title":"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated schwannomas","volume":"288","author":"Licciulli","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109377_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acsmedchemlett.5b00398","article-title":"Design of selective PAK1 inhibitor G-5555: improving properties by employing an unorthodox low-p K a polar moiety","volume":"6","author":"Ndubaku","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109377_bib29","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acs.jmedchem.5b00572","article-title":"Structure-guided design of group I selective p21-activated kinase inhibitors","volume":"58","author":"Crawford","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109377_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e131072","article-title":"Novel glucokinase activators: a structure-based pharmacophore modeling, QSAR analysis, and molecular dynamics approach","volume":"71","author":"Ahmad","year":"2024","journal-title":"Pharmacia"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:07:29Z","timestamp":1780556849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S1093326326001038"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109377","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based pharmacophore modeling and 3D-QSAR analysis toward the discovery of novel PAK1 inhibitors for the treatment of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109377"}}